Para Z-Aid LLC

05/19/2026

https://www.facebook.com/share/v/18fAgurpc7/?mibextid=wwXIfr

05/17/2026

05/17/2026

https://www.facebook.com/share/p/1BCrwiQYyQ/?mibextid=wwXIfr

May is ! Join us on May 20th at 6PM Eastern for a free webinar on Ehlers-Danlos syndrome and dysautonomia. Dr. Amanda Miller, Assistant Professor of Physical Therapy at Lebanon Valley College will discuss what Ehlers-Danlos syndrome is, how it is diagnosed, new research and what we know to date about the relationship between EDS and dysautonomia.

Register for free at bit.ly/2026EDSWebinar

Can't join us live? You can register for the webinar to receive a copy of the recording a few weeks after the live broadcast.

05/17/2026

05/17/2026

05/17/2026

05/17/2026

POTS is often overlooked, especially in complex chronic illnesses. Many doctors aren't taught about POTS in medical school, making it one of the most underdiagnosed and misdiagnosed conditions I see.

MCAS, POTS and hypermobility often present as a triad, and POTS is often part of the threat driving MCAS symptoms. The mistake most clinicians make is treating MCAS first. In my experience, the sequence that works is treating POTS first.

Tomorrow I'm teaching a live two-hour session covering my full MCAS framework: the biology, the diagnostic criteria, the complete treatment protocol with actual dosing, the POTS and hypermobility connection, and the mitochondrial dysfunction that keeps patients stuck when everything else looks right.

If you've been managing symptoms without resolving the pattern, this is where to start.

Comment MCAS to join me live tomorrow.

05/16/2026

Most patients who come to see me with MCAS have done an extraordinary amount of investigative work on their own.

They've removed the obvious food triggers, avoided known environmental exposures, trialled multiple medications. And they're still reacting.

When I go through the list of what they've investigated, one thing is almost never on it: the “inactive” ingredients in their medications and supplements.

Most drugs are made predominantly of excipients: binders, fillers, dyes, coatings, preservatives. Regulatory bodies classify these as inactive and safe. In my experience, that classification is not accurate.

Excipient reactivity is one of the most common (and most overlooked) reasons MCAS patients fail to progress. It's also entirely fixable once you know to look for it.

👉️ Comment PILL if you want to understand the full picture of excipient reactivity in MCAS and I'll send you an article that covers everything you need to know.

Disclaimer: The information shared in this post is for educational and informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for specific medical guidance and treatment.